Shutterstock
In anticipation of CPHI Barcelona, the world's largest pharmaceutical event, often referred to as 'the heart of pharma,' the industry collectively focuses its attention on the manufacturing supply chain. In this context, CPHI expert Emil Ciurczak, from Doramaxx Consulting, sheds light on the often-underappreciated post-pandemic positives. Supply chain resilience, the competing aspects of Process Analytical Technology (PAT), cost reduction strategies, and Quality by Design (QbD) emerge as prominent themes for the 2500 companies in attendance. These topics also form the cornerstone of much of the content at this year's event, with over 50 sessions dedicated to exploring how the industry is poised to evolve in preparation for 2024.